RSNA 2013: Visage’s Top Five

Visage Imaging @ RSNA 2013 For all who attended, thank you for making RSNA 2013 such a success for Visage Imaging.  It was great spending time with customers, demonstrating our latest innovations, and hearing about your plans for enterprise imaging initiatives in 2014.  Similar to last year, we’ve developed our “top five” observations coming out of the conference.  If you had similar or different observations, we’d love to hear about your views on any of our social media platforms.  If you didn’t attend RSNA, we hope you find the observations valuable: 1.  Take the lead.  There’s a great dichotomy that has developed in medical imaging—while there’s an undertone of uncertainty in the US due to a variety of environmental factors, leading imaging organizations are moving forward seizing the opportunity to differentiate and separate from competitors. Visage 7 Workstation As legacy PACS have aged, no organization has coveted upgrading or replacing ‘PACS with PACS’ for negligible gain; however, times have changed.  Whereas conventional solutions offer competitive parity, leading organizations have recognized that Visage 7, independently or in combination with other best of breed solutions, offers dramatic step-change improvements that leapfrog the status quo. Of note, respected industry analyst Frost & Sullivan* explained in their “RSNA 2013 Review”, Visage 7 “emphasized high performance [and] distinguished from other universal viewers as being an end-to-end viewer that can overlay existing PACS viewers and be used across several imaging specialties for primary diagnosis as well as for secondary viewing by clinicians.” While some lessor competitors are strategically comatose, top organizations have decided to break from the pack and move ahead.  Michael Gray was arguably the first to write about this strategy following RSNA 2013, and Joe

Results of Annual General Meeting 2013

Results of Annual General Meeting 2013 - Acrobat pdf 28k 22 November 2013 Pro Medicus announced the results of the Annual General Meeting (AGM), on 22 November 2013.   The results may be downloaded via the above link.

Chairman’s/CEO AGM Presentation 2013

Annual General Meeting November 2013 - Acrobat pdf 2,400k 22 November 2013 On 22 November 2013, Pro Medicus held their Annual General Meeting (AGM).  The Chairman's Address, Chairman's Report, and CEO Address to the AGM are available for download via the above link.

Visage Technology Goes Live at vRad

Visage Technology Goes Live at vRad - Acrobat pdf 28k 21 November 2013 Key Points: First Visage 7 implementation goes live as part of the vRad partnership announced in May 2013 Visage 7 is a key component of vRad’s RG2 (Radiology Group 2.0) solution Visage technology delivers industry leading performance Five-year contract period commences Opens opportunities for further Visage rollout with vRad’s RG2 deployments Leading e-health company Pro Medicus Limited [ASX: PME] today announced that its Visage 7 imaging technology has been successfully implemented as part of RG2SM, vRad’s next- generation radiology operational management solution. RG2 – or Radiology Group 2.0 – optimizes coverage of both onsite and cloud based radiology services using physician productivity tools such as a next-generation radiology reading platform with Visage’s enterprise diagnostic viewer, global worklists and advanced analytics for faster and better decision making. vRad (Virtual Radiologic), based in Minneapolis, Minnesota, USA, is the country’s largest radiology group and telemedicine platform. vRad works in partnership with local radiology groups and hospitals to optimize radiology’s pivotal role in patient care. vRad’s more than 450 radiologists serve over 2,000 radiology groups, hospitals and health systems, reading in excess of 7 million studies annually. “This is an important milestone for us,” said Dr Sam Hupert, Pro Medicus CEO. “Our technology has proven its capability with a partner operating in a high-volume, high-demand healthcare environment. Not only does it provide vRad radiologists with the most comprehensive set of clinical tools in a single product, but it is also exceptionally fast. Unlike others who have to move ever increasing datasets across the network, we are able to instantly stream the images to radiologists’ desktops regardless of the size of the examination they are reading. Faster delivery

PME Signs US $4M Deal with Large Veterans Affairs Network

PME Signs US $4M Deal with Large Veterans Affairs Network - Acrobat pdf 37k 21 October 2013 Key Points: Pro Medicus’ first US government contract Contract is with VISN23 – a large regional veteran affairs network servicing more than 400,000 veterans Pro Medicus’ Visage 7 will be the central component of new, leading-edge technology platform Five-year contract worth more than US $4 million Leading e-health company Pro Medicus [ASX: PME] today announced its wholly-owned subsidiary, Visage Imaging Inc. (“Visage”), has signed a five-year US $4million agreement with VISN23, a large regional veterans affairs network in the United States of America. The VISN23 network, one of 21 Veteran Integrated Service Networks within the Department of Veterans Affairs (VA), serves more than 400,000 enrolled Veterans residing in the states of Iowa, Minnesota, Nebraska, North Dakota, South Dakota and portions of Illinois, Kansas, Missouri, Wisconsin and Wyoming. Under the terms of the agreement, Pro Medicus’ Visage 7 technology will be used for both diagnostic interpretation and clinical (referrer) distribution in all the radiology facilities covered by the network. Dr Sam Hupert, CEO of Pro Medicus Ltd, said, “This is an extremely important sale for Pro Medicus. It is our first US government contract and we expect this may open up further opportunities for us within both the extensive US veterans affairs network and the broader government market. Secondly, it confirms our view that our technology is not limited to just one segment of the radiology market. It is ideally suited to the full spectrum of radiology businesses allowing us to address opportunities ranging from teleradiology/remote reading groups all the way through to large government enterprises.” It is estimated that the rollout of Visage technology will commence in early 2014

PME Signs Deal with vRad

PME Signs Deal with vRad - Acrobat pdf 33k 8 May 2013 Key Points: Visage® 7 to become a central component of vRad’s technology platform vRad employs more than 400 radiologists, reading approximately 7 million studies annually First phase of the Visage 7 rollout is to two East Coast radiology groups in the vRad Alliance with potential for others to follow Transaction-based model has significant upside for PME Leading e-health company Pro Medicus [ASX: PME] today announced its wholly-owned subsidiary, Visage Imaging Inc. (“Visage”), has signed a five-year agreement with vRad (Virtual Radiologic), one the world’s largest radiology groups. vRad, whose more than 400 radiologists read 7 million radiology studies annually, will implement the Visage 7 Enterprise Imaging Platform as a central component of its technology platform focused on delivering a real-time, ‘read anywhere, read anytime’ environment. This will enable vRad to dynamically orchestrate when and by whom studies are read from anywhere within their owned partner radiology groups (hospitals and offsite), as well as their vast teleradiology network. “We performed an extensive analysis of the market before making our decision, “ said Jordan Halter, vRad’s Vice President of Business and Clinical Strategy. “Visage 7’s speed and clinical depth immediately impressed us and we couldn’t be more excited. Visage is a key component of our new technology platform and will enable us to rapidly stream even the largest radiology cases, to the most appropriate radiologist for interpretation, while also providing the most comprehensive clinical tools available.” The first phase of Visage implementations are planned for Diagnostic Imaging, Inc. (DII) and the New York Radiology Alliance (NYRA), both part of the vRad Alliance Network. Mr. Halter added, “I’ve been fortunate to be in Medical Imaging and Medical

Results of Annual General Meeting 2012

Results of Annual General Meeting 2012 - Acrobat pdf 28k 20 November 2012 Pro Medicus announced the results of the Annual General Meeting (AGM), on 20 November 2012.   The results may be downloaded via the above link.

Chairman’s/CEO AGM Presentation 2012

Annual General Meeting November 2012 - Acrobat pdf 2,600k 20 November 2012 On 20 November 2012, Pro Medicus held their Annual General Meeting (AGM).  The Chairman's Address, Chairman's Report, and CEO Address to the AGM are available for download via the above link

Pro Medicus Launches New Technology Platform

Pro Medicus Launches New Technology Platform - Acrobat pdf 34k 30 August 2012 Leading e-health company Pro Medicus Limited [ASX: PME] today announced the launch – and early commercial sales – of the company’s new technology platform to improve and streamline the operations of medical practices. Dr Sam Hupert, Pro Medicus Chief Executive Officer, said the product, code-named Coral, was the culmination of more than four years of work and represents a new generation of radiology Information systems product (RIS). He said the new platform was a unique technology because its integrated workflow and rules- based engines provide unparalleled flexibility for the operation of medical practices. “Crucially, Coral enables us to configure business-specific workflow and rules to suit clients’ needs,” said Dr Hupert. “Being able to tailor the product to such a high degree without needing to customise a program for each customer is a new concept for the radiology industry and will be significant both for clients and the company.” Dr Hupert said Coral has been operating successfully for more than a month in a Melbourne based comprehensive radiology facility which also uses Pro Medicus’ Visage PACS system. “There are significant benefits to be gained by combining our new RIS platform with our existing Visage 7 technology that we do not believe are achievable when integrating products from different companies. It is certainly the case of the whole being greater than the sum of the parts.” Pro Medicus has already received orders for the new technology with implementations scheduled over the coming months. “Whilst it is early days, we believe this new technology platform will further redefine the Practice Management/RIS market and underline Pro Medicus’ position as a leading provider of this technology. With Coral

Pro Medicus Completes Sale of Amira to VSG

Pro Medicus Completes Sale of Amira to VSG - Acrobat pdf 23k 1 August 2012 Leading e-health company Pro Medicus Limited [ASX: PME] today announced that it has completed the sale of the group’s Amira software platform business to Visualization Sciences Group (VSG) a, French IT company, for a cash consideration of €12.1 Million. The Amira business, included as part of the acquisition of Visage Imaging from Mercury Computer Systems in 2009, provides software tool kits for visualizing, manipulating and understanding life science and bio-medical imaging to universities, research institutions as well as to manufacturers of scientific equipment. Sam Hupert, CEO of Pro Medicus, said, “This transaction makes sense for both parties.We bought Visage Imaging for its thin client 3D diagnostic imaging (radiology) technology platform which we have developed into Visage 7®, a world-class range of 2-D/3-D PACS (digital imaging) products. We see our growth in leading edge IT solutions for radiology.” "VSG on the other hand develops and markets high-performance visualization software for developers, engineers and scientists in material science and geoscience markets so I think Amira is an excellent fit for them. It will expand their portfolio significantly." Details of the commercial impact of the deal will be released by the company in its full-year results in mid-August, however according to Dr Hupert, proceeds from the Amira sale will provide significant additional resources to grow the base for the company’s Radiology Practice Management and Visage 7® suite of products in Australia as well as in the key markets of Europe and North America.

Go to Top